Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran.

Int J Prev Med · 2025 · PMC12303401 · PMID 40726952

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantlyno p-value reported

The two groups were found to have no significant differences in terms of gender and current EDSS ( P value = 0.749 and 0.052, respectively), although current EDSS is almost significantly higher in patients with longer disease duration.

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.